The Oncology Institute, Inc.TOINASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+29.3%
5Y CAGR+23.5%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+29.3%/yr
vs +23.2%/yr prior
5Y CAGR
+23.5%/yr
Recent acceleration
Acceleration
+6.1pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.9x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $433.24M | +27.6% |
| 2024 | $339.42M | +28.2% |
| 2023 | $264.67M | +32.1% |
| 2022 | $200.39M | +23.6% |
| 2021 | $162.16M | +7.6% |
| 2020 | $150.64M | +20.1% |
| 2019 | $125.46M | +44.4% |
| 2018 | $86.88M | - |